TIG Advisors LLC’s Global Blood Therapeutics, Inc. GBT Stock Holding History

TIG Advisors LLC’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-696,420	Closed	-$47.4M	–	182
2022 Q3	$47.4M	Buy	+696,420	New	+$38.4M	1.73%	18

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TIG Advisors LLC's GBT Position: Q4 2022 in Review

TIG Advisors LLC sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 696,420 shares — an estimated $47.4M sold.

TIG Advisors LLC first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $47.4M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

TIG Advisors LLC reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
TIG Advisors LLC sold 696,420 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $47.4M.
TIG Advisors LLC first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
TIG Advisors LLC's Global Blood Therapeutics, Inc. position peaked at $47.4M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on TIG Advisors LLC's 13F filing for Q4 2022, filed 14 Feb 2023.